HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

David Q-H Wang Selected Research

Cholic Acid

7/2006Evidence that gallbladder epithelial mucin enhances cholesterol cholelithogenesis in MUC1 transgenic mice.
8/2004Targeted disruption of the murine cholecystokinin-1 receptor promotes intestinal cholesterol absorption and susceptibility to cholesterol cholelithiasis.
3/2004Targeted disruption of the murine mucin gene 1 decreases susceptibility to cholesterol gallstone formation.
11/2002Effect of beta-muricholic acid on the prevention and dissolution of cholesterol gallstones in C57L/J mice.
11/2002Lith genes control mucin accumulation, cholesterol crystallization, and gallstone formation in A/J and AKR/J inbred mice.
11/2002Aging per se is an independent risk factor for cholesterol gallstone formation in gallstone susceptible mice.
7/2002Susceptibility to murine cholesterol gallstone formation is not affected by partial disruption of the HDL receptor SR-BI.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!


Choose Username:
Email:
Password:
Verify Password:


David Q-H Wang Research Topics

Disease

38Gallstones (Gallstone)
10/2015 - 01/2002
13Cholelithiasis
10/2015 - 02/2002
4Body Weight (Weight, Body)
09/2015 - 02/2002
3Fistula
12/2015 - 05/2003
3Obesity
08/2014 - 05/2013
3Fatty Liver
10/2013 - 06/2012
3Insulin Resistance
10/2013 - 11/2010
3Liver Diseases (Liver Disease)
04/2013 - 06/2011
3Hypercholesterolemia
01/2012 - 08/2005
2AIDS-Related Complex (ARC)
09/2015 - 02/2010
2Hepatitis
10/2013 - 06/2011
2Metabolic Diseases (Metabolic Disease)
01/2012 - 06/2008
2Cholestasis
06/2011 - 05/2007
2Atherosclerosis
10/2010 - 09/2007
1Prostatic Neoplasms (Prostate Cancer)
12/2014
1Burns
08/2014
1Wounds and Injuries (Trauma)
08/2014
1Weight Loss (Weight Reduction)
08/2014
1Biliary Liver Cirrhosis (Primary Biliary Cirrhosis)
05/2014
1Autoimmune Diseases (Autoimmune Disease)
05/2014
1Hepatolenticular Degeneration (Wilson's Disease)
06/2011
1Hemochromatosis (Bronze Diabetes)
06/2011
1Dislocations
02/2010
1Inflammation
04/2009
1Overweight
06/2008
1Necrosis
05/2007

Drug/Important Bio-Agent (IBA)

41CholesterolIBA
10/2015 - 01/2002
9ezetimibe (Zetia)FDA Link
12/2014 - 08/2005
9Bile Acids and Salts (Bile Acids)IBA
08/2014 - 11/2002
7Estrogens (Estrogen)FDA Link
10/2015 - 07/2004
7MucinsIBA
02/2010 - 02/2002
7Cholic AcidIBA
07/2006 - 07/2002
4Ursodeoxycholic Acid (Urso)FDA LinkGeneric
08/2014 - 11/2002
4LipidsIBA
05/2014 - 03/2004
4Non-alcoholic Fatty Liver DiseaseIBA
10/2013 - 06/2011
2MicellesIBA
12/2014 - 06/2008
2BilirubinIBA
08/2014 - 05/2011
23-hydroxy-3-methylglutaryl-coenzyme A (HMG-CoA)IBA
01/2014 - 01/2007
2Cytoplasmic and Nuclear Receptors (Nuclear Receptors)IBA
01/2012 - 01/2012
2ApolipoproteinsIBA
08/2009 - 10/2005
2Dietary CholesterolIBA
01/2008 - 10/2005
2Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA
01/2007 - 08/2005
2high density lipoprotein receptorsIBA
07/2002 - 01/2002
1Apolipoproteins AIBA
12/2015
1Glucose (Dextrose)FDA LinkGeneric
09/2015
1GTP-Binding Proteins (G-Protein)IBA
09/2015
1Cholecystokinin (Pancreozymin)IBA
03/2015
1Oral ContraceptivesIBA
12/2014
1MelatoninIBA
08/2014
1VitaminsIBA
08/2014
1Bile Pigments (Bilin)IBA
08/2014
1GlucuronidesIBA
08/2014
1Nitric Oxide (Nitrogen Monoxide)FDA Link
05/2014
1Membrane LipidsIBA
05/2014
1OxidoreductasesIBA
01/2014
1Triglycerides (Triacylglycerol)IBA
10/2013
1Insulin (Novolin)FDA Link
05/2013
1AMP-Activated Protein KinasesIBA
05/2013
1ginsenoside Rb1IBA
05/2013
1Fatty Acids (Saturated Fatty Acids)IBA
01/2012
1Glucagon-Like Peptide 1 (GLP 1)IBA
11/2010
1apolipoprotein A-IV (apolipoprotein AIV)IBA
07/2010
1Estradiol (Estrace)FDA LinkGeneric
07/2010
1Gonadal Steroid Hormones (Sex Hormones)IBA
11/2009
1Apolipoproteins E (ApoE)IBA
08/2009
1LeptinIBA
08/2009
1Messenger RNA (mRNA)IBA
08/2009
1Leptin ReceptorsIBA
08/2009
1PhospholipidsIBA
04/2009
1Lipoproteins (Lipoprotein)IBA
09/2007
1Phospholipid Transfer ProteinsIBA
09/2007
1DisulfidesIBA
05/2007
1AntioxidantsIBA
05/2007
1Glutathione (Reduced Glutathione)IBA
05/2007
1Taurodeoxycholic AcidIBA
05/2007
1Apolipoprotein B-100 (Apo B 100)IBA
10/2005
1Apolipoprotein B-48IBA
10/2005
1Apolipoproteins B (ApoB)IBA
10/2005
1Chylomicron RemnantsIBA
03/2005
1Estrogen Receptor betaIBA
07/2004
1SteroidsIBA
07/2004
1TamoxifenFDA LinkGeneric
07/2004
1diarylpropionitrileIBA
07/2004
1fulvestrant (Faslodex)FDA Link
07/2004
1Conjugated (USP) Estrogens (Premarin)FDA Link
07/2004
1Estrogen Receptor alphaIBA
07/2004
1Hydroxymethylglutaryl CoA Reductases (HMG CoA Reductase)IBA
11/2002
1muricholic acidIBA
11/2002
1Cholesterol 7-alpha-Hydroxylase (Cholesterol 7 alpha Hydroxylase)IBA
11/2002

Therapy/Procedure

2Cholecystectomy
11/2014 - 08/2014
2Laparoscopic Cholecystectomy
04/2013 - 01/2009
1Hormone Replacement Therapy (Therapy, Hormone Replacement)
12/2014
1Artificial Skin
08/2014
1Bariatric Surgery
08/2014
1Caloric Restriction
08/2014